MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical ...
Nevro's HFX iQâ„¢ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
Finanznachrichten3d
Nevro Corp.: Nevro's HFX iQ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally
Nov. 12, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, ...
Yahoo Finance2d
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
November 13, 2024--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable ... The Swoop® ...
Lifehacker on MSN6d
The FDA Is Finally Pulling a Useless Cold Medicine From the Market
Phenylephrine is both the most common decongestant on pharmacy shelves, and arguably the worst at its job. Last year, the FDA ...
New Congress brings churn in health policy leadership
Energy and Commerce Health Subcommittee, Senate Finance to see dramatic changes in January, thanks to retirements, electoral ...
Food Safety News6d
FDA increases enforcement of import laws related to heavy metals, illegal colors and more
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed. Recent ...
Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients ...
Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...
Want to crack down on drug cartels? Go after the money launderers | Column
A recent case involving over $400 million provides the latest example of how corrupt banks get off easy even when they should ...
Business Insider2d
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared ...
Implantica Submits FDA PMA Application Clinical Module 2 For Refluxstoptm For U.S. Market Approval
Implantica submits FDA PMA application Clinical Module 2 for RefluxStopâ„¢ for U.S. market approval ...